Related Articles
Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas
Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds
Search for mutations in signaling pathways in head and neck squamous cell carcinoma
Combining AZD8931, a novel EGFR/HER2/HER3 signalling inhibitor, with AZD5363 limits AKT inhibitor induced feedback and enhances antitumour efficacy in HER2-amplified breast cancer models
S100A4 interacts with mutant p53 and affects gastric cancer MKN1 cell autophagy and differentiation